Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01037_DB06204_nanopub.RAD9UO7ZjFyE15CBEMqnuptdG9u9jJ-QKH3dj7eL6QypM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01037_DB06204 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01037_DB06204 label "DDI between Selegiline and Tapentadol - Increases the toxicity of tapentadol by unknown mechanism. Discontinue selegiline at least 14 days prior to tapentadol administration. [drugbank_resource:DB01037_DB06204]" assertion.
- drugbank_resource:DB01037_DB06204 identifier "drugbank_resource:DB01037_DB06204" assertion.
- drugbank_resource:DB01037_DB06204 title "DDI between Selegiline and Tapentadol - Increases the toxicity of tapentadol by unknown mechanism. Discontinue selegiline at least 14 days prior to tapentadol administration." assertion.
- drugbank:DB01037 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01037_DB06204 assertion.
- drugbank:DB06204 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01037_DB06204 assertion.